01 1Kyowa Pharma Chemical Co., Ltd.
01 1Cepetaprost (for manufacturing purposes only)
01 1Japan
Sepetaprost (for manufacturing purposes only)
Registration Number : 306MF10060
Registrant's Address : 530 Chokeiji, Takaoka City, Toyama Prefecture
Initial Date of Registration : 2024-04-24
Latest Date of Registration : 2025-07-03
85
PharmaCompass offers a list of Sepetaprost API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sepetaprost manufacturer or Sepetaprost supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sepetaprost manufacturer or Sepetaprost supplier.
PharmaCompass also assists you with knowing the Sepetaprost API Price utilized in the formulation of products. Sepetaprost API Price is not always fixed or binding as the Sepetaprost Price is obtained through a variety of data sources. The Sepetaprost Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sepetaprost manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sepetaprost, including repackagers and relabelers. The FDA regulates Sepetaprost manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sepetaprost API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sepetaprost supplier is an individual or a company that provides Sepetaprost active pharmaceutical ingredient (API) or Sepetaprost finished formulations upon request. The Sepetaprost suppliers may include Sepetaprost API manufacturers, exporters, distributors and traders.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Sepetaprost Drug Master File in Japan (Sepetaprost JDMF) empowers Sepetaprost API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Sepetaprost JDMF during the approval evaluation for pharmaceutical products. At the time of Sepetaprost JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Sepetaprost suppliers with JDMF on PharmaCompass.
We have 1 companies offering Sepetaprost
Get in contact with the supplier of your choice:
